Apply on Employer Site

Biogen · 5 hours ago

Intern, Biostatistics

United States

Internship

Remote

Intern

Biogen is a mid-sized biotechnology company committed to excellence and innovation. They are seeking interns for their Biostatistics Department to provide statistical support across Research and Development, collaborating on clinical development plans and decision frameworks.

BiotechnologyHealth CareNeuroscienceTherapeutics

Comp. & Benefits

H1B Sponsor Likely

Responsibilities

Read and synthesize key methodology papers

Efficiently develop analysis/simulation code in R or python or another statistical package

Explore results in a systematic way

Document and package new code in a user-friendly way

Prepare a final technical write-up and presentation

Qualification

Statistical analysisRPythonSASBiotechnology knowledgeData translation

Required

Experience of performing statistical analysis with R, SAS, python, or other statistical packages

Knowledge or interest working in biotechnology industry

Ability to translate data into business insights

Legal authorization to work in the U.S

At least 18 years of age prior to the scheduled start date

Currently enrolled in an accredited community college, college, university or skills program/apprenticeship

Graduate school pursuing PhD in statistics, biostatistics, or similar

Benefits

Company paid holidays

Commuter benefits

Employee Resource Groups participation

80 hours of sick time per calendar year

Company

Biogen

Glassdoor3.8

Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.

Founded in 1978

Cambridge, Massachusetts, USA

5001-10000 employees

https://www.biogen.com/en_us/home.html

H1B Sponsorship

Biogen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2025 (100)

2024 (93)

2023 (101)

2022 (134)

2021 (104)

2020 (114)

Funding

Current Stage

Public Company

Total Funding

$1.5B

Key Investors

JP Morgan

2023-08-28Post Ipo Debt· $1.5B

1991-09-27IPO

Leadership Team

Robin C. Kramer

Executive Vice President, Chief Financial Officer

Priya Singhal

Executive Vice President, Head of Development

Recent News

BioSpace

4 Next-Gen Candidates That Could Form the Future of Alzheimer’s Treatment

2026-01-19

Twin Cities

Wall Street slumps as bank and tech stocks fall

2026-01-16

Investing.com

Biogen CEO says at-home Alzheimer’s drug will give edge over Lilly

2026-01-16

Company data provided by crunchbase